{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:11:44Z","timestamp":1783098704546,"version":"3.54.6"},"reference-count":124,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Many probiotic strains have been studied in relation to irritable bowel syndrome (IBS). The aim of this study was to identify probiotic strains demonstrating efficacy in the management of IBS based on meta-analyses of randomized placebo-controlled trials (RPCTs). Methods: This systematic review was registered in the PROSPERO database (CRD420251047092). Searches were conducted in PubMed and Scopus on 8 April 2025. Additional completed studies with available results were identified through ClinicalTrials.gov. An additional search of the Cochrane Central Register of Controlled Trials (CENTRAL), including records indexed in EMBASE, was conducted in December 2025 and did not identify any additional studies. RPCTs were included if they evaluated single-strain probiotics without additional active components compared with a placebo in patients with IBS. Studies whose results could not be meta-analyzed were excluded. Results: A total of 2643 records were identified; 32 articles evaluating 10 probiotic strains were included in the meta-analyses. Meta-analyses demonstrated the efficacy of Bifidobacterium longum (formerly Bifidobacterium infantis) 35624, Lactobacillus rhamnosus GG, Lactiplantibacillus plantarum 299v (DSM 9843), Saccharomyces cerevisiae CNCM I-3856, and Bacillus coagulans Unique IS2 (MTCC 5260) in improving key IBS symptoms. Meta-analyses also demonstrated that Bacillus coagulans MTCC 5856 improved quality of life for those with IBS. Conflicting results were observed for Saccharomyces boulardii CNCM I-745. Meta-analyses did not demonstrate the efficacy of Escherichia coli Nissle 1917, Lactobacillus gasseri BNR17, or Lactobacillus casei Shirota. Conclusions: Several probiotic strains demonstrated efficacy in the treatment of IBS in meta-analyses of RPCTs.<\/jats:p>","DOI":"10.3390\/jcm15031152","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T12:00:47Z","timestamp":1770033647000},"page":"1152","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Strain-Specific Systematic Review with Meta-Analysis of Probiotics Efficacy in the Treatment of Irritable Bowel Syndrome"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7513-1636","authenticated-orcid":false,"given":"Roman","family":"Maslennikov","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Gastroenterology and Hepatology, Sechenov University, Moscow 119435, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1541-4439","authenticated-orcid":false,"given":"Eva","family":"Gosteeva","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Gastroenterology and Hepatology, Sechenov University, Moscow 119435, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Ananeva","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Gastroenterology and Hepatology, Sechenov University, Moscow 119435, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lada","family":"Korshunova","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Gastroenterology and Hepatology, Sechenov University, Moscow 119435, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasya","family":"Kravtsowa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Gastroenterology and Hepatology, Sechenov University, Moscow 119435, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Poluektova","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Gastroenterology and Hepatology, Sechenov University, Moscow 119435, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anatoly","family":"Ulyanin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Gastroenterology and Hepatology, Sechenov University, Moscow 119435, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey","family":"Sigidaev","sequence":"additional","affiliation":[{"name":"Department of Clinical Disciplines, Tyumen State Medical University, Tyumen 625023, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patimat","family":"Kikhasurova","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Gastroenterology and Hepatology, Sechenov University, Moscow 119435, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Ivashkin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Gastroenterology and Hepatology, Sechenov University, Moscow 119435, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.22416\/1382-4376-2021-31-5-74-95","article-title":"Diagnosis and Treatment of Irritable Bowel Syndrome: Clinical Recommendations of the Russian Gastroenterological Association and Association of Coloproctologists of Russia","volume":"31","author":"Ivashkin","year":"2021","journal-title":"Russ. J. Gastroenterol. Hepatol. Coloproctol."},{"key":"ref_2","first-page":"76","article-title":"Irritable bowel syndrome","volume":"158","year":"2022","journal-title":"Med. Cl\u00edn."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.3748\/wjg.v29.i26.4120","article-title":"Irritable bowel syndrome: Epidemiology, overlap disorders, pathophysiology and treatment","volume":"29","author":"Huang","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1080\/17474124.2023.2223975","article-title":"Irritable bowel syndrome\u2014Controversies in diagnosis and management","volume":"17","author":"Duncanson","year":"2023","journal-title":"Expert. Rev. Gastroenterol. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/gutjnl-2022-328515","article-title":"Irritable bowel syndrome: Treatment based on pathophysiology and biomarkers","volume":"72","author":"Camilleri","year":"2023","journal-title":"Gut"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/1751-2980.13204","article-title":"Gut microbiota and irritable bowel syndrome","volume":"24","author":"Zhao","year":"2023","journal-title":"J. Dig. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1080\/1040841X.2022.2058353","article-title":"Bile acid\u2013gut microbiota crosstalk in irritable bowel syndrome","volume":"49","author":"Gu","year":"2023","journal-title":"Crit. Rev. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Cheng, X., Ren, C., Mei, X., Jiang, Y., and Zhou, Y. (2024). Gut microbiota and irritable bowel syndrome: Status and prospect. Front. Med., 11.","DOI":"10.3389\/fmed.2024.1429133"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Xie, P., Luo, M., Deng, X., Fan, J., and Xiong, L. (2023). Outcome-specific efficacy of different probiotic strains and mixtures in irritable bowel syndrome: A systematic review and network meta-analysis. Nutrients, 15.","DOI":"10.3390\/nu15173856"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1053\/j.gastro.2023.07.018","article-title":"Efficacy of probiotics in irritable bowel syndrome: Systematic review and meta-analysis","volume":"165","author":"Goodoory","year":"2023","journal-title":"Gastroenterology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"001758","DOI":"10.1099\/jmm.0.001758","article-title":"Efficacy of probiotics, prebiotics and synbiotics in irritable bowel syndrome: A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials","volume":"72","author":"Zhang","year":"2023","journal-title":"J. Med. Microbiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.18295\/squmj.2020.20.01.003","article-title":"Efficacy and safety of probiotics, prebiotics and synbiotics in the treatment of irritable bowel syndrome: A systematic review and meta-analysis","volume":"20","author":"Asha","year":"2020","journal-title":"Sultan Qaboos Univ. Med. J."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Zhang, T., Zhang, C., Zhang, J., Sun, F., and Duan, L. (2022). Efficacy of probiotics for irritable bowel syndrome: A systematic review and network meta-analysis. Front. Cell. Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.859967"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e16068","DOI":"10.1097\/MD.0000000000016068","article-title":"Efficacy of different probiotic protocols in irritable bowel syndrome: A network meta-analysis","volume":"98","author":"Liang","year":"2019","journal-title":"Medicine"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Li, L., Guo, C., Mu, D., Feng, B., Zuo, X., and Li, Y. (2016). Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: A meta-analysis. BMC Gastroenterol., 16.","DOI":"10.1186\/s12876-016-0470-z"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijsu.2020.01.142","article-title":"The efficacy and safety of probiotics in patients with irritable bowel syndrome: Evidence based on 35 randomized controlled trials","volume":"75","author":"Niu","year":"2020","journal-title":"Int. J. Surg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijsu.2020.04.063","article-title":"The efficacy and safety of probiotics for patients with constipation-predominant irritable bowel syndrome: A systematic review and meta-analysis","volume":"79","author":"Wen","year":"2020","journal-title":"Int. J. Surg."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Ceccherini, C., Daniotti, S., Bearzi, C., and Re, I. (2022). Evaluating the efficacy of probiotics in IBS treatment using a systematic review of clinical trials and multi-criteria decision analysis. Nutrients, 14.","DOI":"10.3390\/nu14132689"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1097\/JS9.0000000000000658","article-title":"Probiotics for the management of irritable bowel syndrome: A systematic review and three-level meta-analysis","volume":"109","author":"Chen","year":"2023","journal-title":"Int. J. Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/apt.15001","article-title":"Systematic review with meta-analysis: The efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome","volume":"48","author":"Ford","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Le Morvan de Sequeira, C., Kaeber, M., Cekin, S.E., Enck, P., and Mack, I. (2021). The effect of probiotics on quality of life, depression and anxiety in patients with irritable bowel syndrome: A systematic review and meta-analysis. J. Clin. Med., 10.","DOI":"10.3390\/jcm10163497"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1163\/18762891-20220134","article-title":"Systematic review with meta-analysis: Effects of probiotic fungi on irritable bowel syndrome","volume":"14","author":"Qing","year":"2023","journal-title":"Benef. Microbes"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3920\/BM2021.0123","article-title":"Comparing probiotic and drug interventions in irritable bowel syndrome: A meta-analysis of randomised controlled trials","volume":"13","author":"Schukking","year":"2022","journal-title":"Benef. Microbes"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Xie, C.R., Tang, B., Shi, Y.Z., Peng, W.Y., Ye, K., Tao, Q.F., Yu, S.G., Zheng, H., and Chen, M. (2022). Low FODMAP diet and probiotics in irritable bowel syndrome: A systematic review with network meta-analysis. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.853011"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.clnu.2023.03.019","article-title":"Efficacy and safety of probiotics in the treatment of irritable bowel syndrome: A systematic review and meta-analysis of randomised clinical trials using Rome IV criteria","volume":"42","author":"Konstantis","year":"2023","journal-title":"Clin. Nutr."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Wu, Y., Li, Y., Zheng, Q., and Li, L. (2024). The efficacy of probiotics, prebiotics, synbiotics, and fecal microbiota transplantation in irritable bowel syndrome: A systematic review and network meta-analysis. Nutrients, 16.","DOI":"10.3390\/nu16132114"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.clnesp.2024.02.025","article-title":"Efficacy and safety of probiotics in irritable bowel syndrome: A systematic review and meta-analysis","volume":"60","author":"Yang","year":"2024","journal-title":"Clin. Nutr. ESPEN"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Li, B., Liang, L., Deng, H., Guo, J., Shu, H., and Zhang, L. (2020). Efficacy and safety of probiotics in irritable bowel syndrome: A systematic review and meta-analysis. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.00332"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Shang, X., E, F.F., Guo, K.L., Li, Y.F., Zhao, H.L., Wang, Y., Chen, N., Nian, T., Yang, C.Q., and Yang, K.H. (2022). Effectiveness and safety of probiotics for patients with constipation-predominant irritable bowel syndrome: A systematic review and meta-analysis. Nutrients, 14.","DOI":"10.3390\/nu14122482"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4103\/sjg.SJG_384_19","article-title":"Efficacy and safety of probiotics in irritable bowel syndrome: A systematic review and meta-analysis","volume":"26","author":"Sun","year":"2020","journal-title":"Saudi J. Gastroenterol."},{"key":"ref_31","first-page":"e75954","article-title":"Efficacy of probiotics in the management of irritable bowel syndrome: A systematic review and meta-analysis","volume":"16","author":"Almabruk","year":"2024","journal-title":"Cureus"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1007\/s00384-022-04261-0","article-title":"Probiotics therapy for adults with diarrhea-predominant irritable bowel syndrome: A systematic review and meta-analysis","volume":"37","author":"Wang","year":"2022","journal-title":"Int. J. Color. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"101154","DOI":"10.1016\/j.eclinm.2021.101154","article-title":"Strain-specific and outcome-specific efficacy of probiotics for the treatment of irritable bowel syndrome: A systematic review and meta-analysis","volume":"41","author":"McFarland","year":"2021","journal-title":"eClinicalMedicine"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/nutrit\/nuae217","article-title":"Effects of probiotics and diet management in patients with irritable bowel syndrome: A systematic review and network meta-analysis","volume":"83","author":"Lei","year":"2025","journal-title":"Nutr. Rev."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Anwar, D.F.F., Salma, Z.N., Oktaviani, S.D., Adiyatma, F.N., Tauhid, F.M., Mustofa, A., Saputra, P.B.T., Karimah, R., and Alkaff, F.F. (2025). Effect of multistrain probiotics on symptom severity in irritable bowel syndrome: A systematic review and meta-analysis of irritable bowel syndrome-symptom severity score outcomes. Eur. J. Gastroenterol. Hepatol.","DOI":"10.1097\/MEG.0000000000003074"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e1343","DOI":"10.1093\/nutrit\/nuae107","article-title":"Nutritional interventions in adult patients with irritable bowel syndrome: An umbrella review of systematic reviews and meta-analyses of randomized clinical trials","volume":"83","author":"Ranjbar","year":"2025","journal-title":"Nutr. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/MEG.0000000000003062","article-title":"Comparative effectiveness and safety of probiotics with psychotropic potential in irritable bowel syndrome: A systematic review and network meta-analysis","volume":"38","author":"Rokkas","year":"2026","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/jgh.16858","article-title":"Probiotics combined with trimebutine for the treatment of irritable bowel syndrome patients: A systematic review and meta-analysis","volume":"40","author":"Yu","year":"2025","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3164\/jcbn.15-14","article-title":"Effect of administering a multi-species probiotic mixture on fecal microbiota and symptoms of irritable bowel syndrome: A randomized controlled trial","volume":"57","author":"Yoon","year":"2015","journal-title":"J. Clin. Biochem. Nutr."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3109\/00365521.2011.565066","article-title":"Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: A randomized controlled trial","volume":"46","author":"Olsson","year":"2011","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1365-2036.2009.04183.x","article-title":"Clinical trial: Effects of a fermented milk containing three probiotic bacteria in irritable bowel syndrome","volume":"31","author":"Olsson","year":"2010","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/MCG.0b013e31823712b1","article-title":"Effect of a multispecies probiotic mixture in diarrhea-dominant irritable bowel syndrome","volume":"46","author":"Cha","year":"2012","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"824605","DOI":"10.1155\/2013\/824605","article-title":"Effect of Korean herbal medicine combined with a probiotic mixture on diarrhea-dominant irritable bowel syndrome","volume":"2013","author":"Ko","year":"2013","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1046\/j.1365-2036.2003.01543.x","article-title":"A randomized controlled trial of a probiotic, VSL#3, in diarrhea-predominant irritable bowel syndrome","volume":"17","author":"Kim","year":"2003","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-2982.2005.00695.x","article-title":"A randomized controlled trial of probiotic combination VSL#3 in irritable bowel syndrome with bloating","volume":"17","author":"Kim","year":"2005","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/MPG.0b013e3181ca4d95","article-title":"VSL#3 improves symptoms in children with irritable bowel syndrome","volume":"51","author":"Guandalini","year":"2010","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1053\/j.gastro.2017.06.010","article-title":"A diet low in FODMAPs reduces symptoms in irritable bowel syndrome and a probiotic restores bifidobacteria","volume":"153","author":"Staudacher","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2036.2007.03362.x","article-title":"Effect of fermented milk containing Bifidobacterium animalis DN-173 010 in irritable bowel syndrome","volume":"26","author":"Guyonnet","year":"2007","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1365-2036.2008.03853.x","article-title":"Fermented milk containing Bifidobacterium lactis DN-173 010 in IBS with constipation","volume":"29","author":"Agrawal","year":"2009","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2036.2005.02579.x","article-title":"A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: A controlled 6-month intervention","volume":"22","author":"Kajander","year":"2005","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_51","first-page":"156","article-title":"The efficacy of a synbiotic containing Bacillus coagulans in irritable bowel syndrome","volume":"7","author":"Rogha","year":"2014","journal-title":"Gastroenterol. Hepatol. Bed Bench"},{"key":"ref_52","first-page":"1344","article-title":"Efficacy and safety of simethicone plus Bacillus coagulans in irritable bowel syndrome","volume":"18","author":"Urgesi","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4161\/gmic.24196","article-title":"Fecal excretion of Bifidobacterium infantis 35624 after oral supplementation","volume":"4","author":"Charbonneau","year":"2013","journal-title":"Gut Microbes"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.gastro.2004.11.050","article-title":"Lactobacillus and bifidobacterium in irritable bowel syndrome","volume":"128","author":"McCarthy","year":"2005","journal-title":"Gastroenterology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/j.1572-0241.2006.00734.x","article-title":"Efficacy of Bifidobacterium infantis 35624 in women with irritable bowel syndrome","volume":"101","author":"Whorwell","year":"2006","journal-title":"Am. J. Gastroenterol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jpeds.2005.05.015","article-title":"The use of Lactobacillus GG in irritable bowel syndrome in children: A double-blind randomized controlled trial","volume":"147","author":"Bauserman","year":"2005","journal-title":"J. Pediatr."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e1445","DOI":"10.1542\/peds.2010-0467","article-title":"A randomized controlled trial of Lactobacillus GG in children with functional abdominal pain","volume":"126","author":"Francavilla","year":"2010","journal-title":"Pediatrics"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2036.2006.03175.x","article-title":"A randomized double-blind placebo-controlled trial of Lactobacillus GG for abdominal pain disorders in children","volume":"25","author":"Dziechciarz","year":"2007","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_61","first-page":"1255","article-title":"Probiotic for irritable bowel syndrome in pediatric patients: A randomized controlled clinical trial","volume":"7","author":"Kianifar","year":"2015","journal-title":"Electron. Physician"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S1590-8658(00)80021-3","article-title":"Bacterial supplementation in the irritable bowel syndrome: A randomised double-blind placebo-controlled crossover study","volume":"32","year":"2000","journal-title":"Dig. Liver Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.3748\/wjg.v18.i30.4012","article-title":"Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome","volume":"18","author":"Sawant","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"ref_64","first-page":"404","article-title":"Role of Lactobacillus plantarum 299v versus placebo in symptomatic improvement of irritable bowel syndrome patients","volume":"72","author":"Babar","year":"2022","journal-title":"J. Pak. Med. Assoc."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1097\/00042737-200110000-00004","article-title":"A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome","volume":"13","author":"Niedzielin","year":"2001","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1572-0241.2000.02015.x","article-title":"Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome","volume":"95","author":"Nobaek","year":"2000","journal-title":"Am. J. Gastroenterol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.nut.2014.02.010","article-title":"Randomized clinical trial: Effect of Lactobacillus plantarum 299v on symptoms of irritable bowel syndrome","volume":"30","author":"Stevenson","year":"2014","journal-title":"Nutrition"},{"key":"ref_68","first-page":"84","article-title":"Probiotic effect and dietary correlations on faecal microbiota profiles in irritable bowel syndrome","volume":"34","author":"Stevenson","year":"2019","journal-title":"S. Afr. J. Clin. Nutr."},{"key":"ref_69","first-page":"201","article-title":"Efficacy of probiotic Escherichia coli Nissle 1917 in patients with irritable bowel syndrome: A double-blind placebo-controlled randomized trial","volume":"47","author":"Faghihi","year":"2015","journal-title":"Acta Med. Indones."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00384-011-1363-9","article-title":"A double-blind placebo-controlled trial of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome","volume":"27","author":"Kruis","year":"2012","journal-title":"Int. J. Color. Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00384-019-03462-4","article-title":"Efficacy of Saccharomyces cerevisiae CNCM I-3856 as add-on therapy for irritable bowel syndrome","volume":"35","author":"Gayathri","year":"2020","journal-title":"Int. J. Color. Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.3748\/wjg.v28.i22.2509","article-title":"Saccharomyces cerevisiae I-3856 in irritable bowel syndrome with predominant constipation","volume":"28","author":"Mourey","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.dld.2014.11.007","article-title":"A randomized clinical trial of Saccharomyces cerevisiae versus placebo in irritable bowel syndrome","volume":"47","author":"Neut","year":"2015","journal-title":"Dig. Liver Dis."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/2050640615602571","article-title":"Randomized double-blind placebo-controlled trial of Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome","volume":"4","author":"Spiller","year":"2016","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s10068-017-0296-7","article-title":"Effect of Lactobacillus gasseri BNR17 on irritable bowel syndrome: A randomized, double-blind, placebo-controlled trial","volume":"27","author":"Kim","year":"2017","journal-title":"Food Sci. Biotechnol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3164\/jcbn.17-73","article-title":"Lactobacillus gasseri BNR17 mitigates diarrhea-dominant irritable bowel syndrome","volume":"62","author":"Shin","year":"2018","journal-title":"J. Clin. Biochem. Nutr."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"12210","DOI":"10.1038\/s41598-019-48554-x","article-title":"Randomized clinical trial: The effect of probiotic Bacillus coagulans Unique IS2 vs. placebo on the symptoms management of irritable bowel syndrome in adults","volume":"9","author":"Madempudi","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3920\/BM2017.0129","article-title":"Efficacy of Bacillus coagulans Unique IS2 in children with irritable bowel syndrome","volume":"9","author":"Sudha","year":"2018","journal-title":"Benef. Microbes"},{"key":"ref_79","first-page":"56","article-title":"Essai randomis\u00e9 de Saccharomyces boulardii dans le traitement des colopathies fonctionnelles","volume":"73","author":"Bennani","year":"1990","journal-title":"L\u2019Objectif M\u00e9dical"},{"key":"ref_80","first-page":"77","article-title":"Traitement des colopathies fonctionnelles: Essai en double aveugle de Saccharomyces boulardii","volume":"12","author":"Maupas","year":"1983","journal-title":"Med. Chir. Dig."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/MEG.0000000000000094","article-title":"Cytokine and clinical response to Saccharomyces boulardii therapy in diarrhea-dominant irritable bowel syndrome","volume":"26","author":"Abbas","year":"2014","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/MCG.0b013e318204593e","article-title":"A randomized, double-blind, placebo-controlled trial of Saccharomyces boulardii in irritable bowel syndrome","volume":"45","author":"Choi","year":"2011","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_83","first-page":"397","article-title":"Role of Saccharomyces boulardii in diarrhea-predominant irritable bowel syndrome","volume":"20","author":"Kabir","year":"2011","journal-title":"Mymensingh Med. J."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12937-016-0140-6","article-title":"Bacillus coagulans MTCC 5856 in diarrhea-predominant irritable bowel syndrome","volume":"15","author":"Majeed","year":"2016","journal-title":"Nutr. J."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.29219\/fnr.v62.1218","article-title":"Bacillus coagulans MTCC 5856 for the management of major depression with irritable bowel syndrome: A randomised, double-blind, placebo controlled, multi-centre, pilot clinical study","volume":"62","author":"Majeed","year":"2018","journal-title":"Food Nutr. Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/MEG.0000000000000484","article-title":"Efficacy of Lactobacillus casei Shirota in irritable bowel syndrome","volume":"28","author":"Thijssen","year":"2016","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1358\/mf.2009.31.10.1441078","article-title":"Effects of a proprietary Bacillus coagulans preparation in diarrhea-predominant irritable bowel syndrome","volume":"31","author":"Dolin","year":"2009","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3810\/pgm.2009.03.1984","article-title":"Bacillus coagulans significantly improved abdominal pain and bloating in patients with irritable bowel syndrome","volume":"121","author":"Hun","year":"2009","journal-title":"Postgrad. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S2468-1253(20)30056-X","article-title":"Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: A multicentre, randomised, double-blind, placebo-controlled clinical trial","volume":"5","author":"Andresen","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Li, X., Yuan, Q., Huang, H., and Wang, L. (2025). Gut microbiota in irritable bowel syndrome: A narrative review of mechanisms and microbiome-based therapies. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1695321"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Kezer, G., Paramithiotis, S., Khwaldia, K., Harahap, I.A., \u010cagalj, M., \u0160imat, V., Smaoui, S., Elfalleh, W., Ozogul, F., and Esatbeyoglu, T. (2025). A comprehensive overview of the effects of probiotics, prebiotics and synbiotics on the gut-brain axis. Front. Microbiol., 16.","DOI":"10.3389\/fmicb.2025.1651965"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Rana, A. (2025). Probiotics: Mechanism of action and gastrointestinal health: Gut guardians: Unlocking the power of probiotics. J. Sci. Food Agric.","DOI":"10.1002\/jsfa.70275"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4161\/gmic.22973","article-title":"The intestinal microbiome, probiotics and prebiotics in neurogastroenterology","volume":"4","author":"Saulnier","year":"2013","journal-title":"Gut Microbes"},{"key":"ref_94","first-page":"98","article-title":"Probiotic vs. Placebo in Irritable Bowel Syndrome: A Randomized Controlled Trial","volume":"5","author":"Amirimani","year":"2013","journal-title":"Middle East. J. Dig. Dis."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1053\/j.gastro.2017.05.003","article-title":"Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients with Irritable Bowel Syndrome","volume":"153","author":"Hall","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Ligaarden, S.C., Axelsson, L., Naterstad, K., Lydersen, S., and Farup, P.G. (2010). A candidate probiotic with unfavourable effects in subjects with irritable bowel syndrome: A randomised controlled trial. BMC Gastroenterol., 10.","DOI":"10.1186\/1471-230X-10-16"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"214102","DOI":"10.1155\/2012\/214102","article-title":"Probiotics, symptoms, and gut microbiota: What are the relations? A randomized controlled trial in subjects with irritable bowel syndrome","volume":"2012","author":"Farup","year":"2012","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Skrzyd\u0142o-Radoma\u0144ska, B., Prozorow-Kr\u00f3l, B., Kurzeja-Miros\u0142aw, A., Cicho\u017c-Lach, H., Laskowska, K., Majsiak, E., Bier\u0142a, J.B., Agnieszka, S., and Cukrowska, B. (2023). The Efficacy and Safety of Single-Strain Probiotic Formulations Containing Bifidobacterium lactis or Bacillus coagulans in Adult Patients with Irritable Bowel Syndrome-A Randomized Double-Blind Placebo-Controlled Three-Arm Interventional Trial. J. Clin. Med., 12.","DOI":"10.3390\/jcm12144838"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e39134","DOI":"10.1097\/MD.0000000000039134","article-title":"Role of Bacillus coagulans (Heyndrickxia coagulans) BCP92 in managing irritable bowel syndrome: A randomized, double-blind, multicenter, placebo-controlled clinical trial","volume":"103","author":"Shaikh","year":"2024","journal-title":"Medicine"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e23641","DOI":"10.1097\/MD.0000000000023641","article-title":"Efficacy and safety of Bacillus coagulans LBSC in irritable bowel syndrome: A prospective, interventional, randomized, double-blind, placebo-controlled clinical study [CONSORT Compliant]","volume":"100","author":"Gupta","year":"2021","journal-title":"Medicine"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Kallur, R.K., Madapati, S., Mathur, A., and Bhattacharya, S. (2024). The role of Weizmannia (Bacillus) coagulans LMG S-31876 in treating IBS-diarrhea. Front. Nutr., 10.","DOI":"10.3389\/fnut.2023.1310462"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2122668","DOI":"10.1080\/19490976.2022.2122668","article-title":"The probiotic Bacillus subtilis BS50 decreases gastrointestinal symptoms in healthy adults: A randomized, double-blind, placebo-controlled trial","volume":"14","author":"Garvey","year":"2022","journal-title":"Gut Microbes"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1007\/s00394-024-03398-8","article-title":"Acacia fiber or probiotic supplements to relieve gastrointestinal complaints in patients with constipation-predominant IBS: A 4-week randomized double-blinded placebo-controlled intervention trial","volume":"63","author":"JanssenDuijghuijsen","year":"2024","journal-title":"Eur. J. Nutr."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1365-2036.2011.04633.x","article-title":"Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study","volume":"33","author":"Guglielmetti","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Lewis, E.D., Antony, J.M., Crowley, D.C., Piano, A., Bhardwaj, R., Tompkins, T.A., and Evans, M. (2020). Efficacy of Lactobacillus paracasei HA-196 and Bifidobacterium longum R0175 in Alleviating Symptoms of Irritable Bowel Syndrome (IBS): A Randomized, Placebo-Controlled Study. Nutrients, 12.","DOI":"10.3390\/nu12041159"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2338322","DOI":"10.1080\/19490976.2024.2338322","article-title":"A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live Bifidobacterium longum CECT 7347 (ES1) and heat-treated Bifidobacterium longum CECT 7347 (HT-ES1) in participants with diarrhea-predominant irritable bowel syndrome","volume":"16","author":"Srivastava","year":"2024","journal-title":"Gut Microbes"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.clnu.2005.06.001","article-title":"The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome\u2014A double blind, placebo-controlled, randomized study","volume":"24","author":"Niv","year":"2005","journal-title":"Clin Nutr."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Martoni, C.J., Srivastava, S., and Leyer, G.J. (2020). Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 Improve Abdominal Pain Severity and Symptomology in Irritable Bowel Syndrome: Randomized Controlled Trial. Nutrients, 12.","DOI":"10.3390\/nu12020363"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1055\/s-2008-1027702","article-title":"Randomized controlled treatment trial of irritable bowel syndrome with a probiotic E.-coli preparation (DSM17252) compared to placebo","volume":"47","author":"Enck","year":"2009","journal-title":"Z. Gastroenterol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"22384","DOI":"10.1038\/s41598-024-72887-x","article-title":"Effect of Lacticaseibacillus rhamnosus IDCC 3201 on irritable bowel syndrome with constipation: A randomized, double-blind, and placebo-controlled trial","volume":"14","author":"Kwon","year":"2024","journal-title":"Sci Rep."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.3390\/nu14102015","article-title":"Effect of Oral Intake of Lactiplantibacillus plantarum APsulloc 331261 (GTB1TM) on Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study","volume":"14","author":"Jung","year":"2022","journal-title":"Nutrients"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.3748\/wjg.v29.i28.4451","article-title":"Efficacy and dose response of Lactiplantibacillus plantarum in diarrhea-predominant irritable bowel syndrome","volume":"29","author":"Martoni","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"194","DOI":"10.5056\/jnm23184","article-title":"The Effects of Fermented Rice Drink with Lactiplantibacillus plantarum JSA22 in Overweight Irritable Bowel Syndrome Patients: A Randomized, Double-blind, Placebo-controlled Study","volume":"30","author":"Kim","year":"2024","journal-title":"J. Neurogastroenterol. Motil."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Yang, B., Yue, Y., Chen, Y., Ding, M., Li, B., Wang, L., Wang, Q., Stanton, C., Ross, R.P., and Zhao, J. (2021). Lactobacillus plantarum CCFM1143 Alleviates Chronic Diarrhea via Inflammation Regulation and Gut Microbiota Modulation: A Double-Blind, Randomized, Placebo-Controlled Study. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.746585"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"10631","DOI":"10.3748\/wjg.v22.i48.10631","article-title":"Irritable bowel syndrome symptom severity improves equally with probiotic and placebo","volume":"22","author":"Lyra","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1007\/s10620-007-0196-4","article-title":"Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome","volume":"53","author":"Sinn","year":"2008","journal-title":"Dig Dis Sci."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1751-0759-6-16","article-title":"The effect of Lactobacillus brevis KB290 against irritable bowel syndrome: A placebo-controlled double-blind crossover trial","volume":"6","author":"Murakami","year":"2012","journal-title":"Biopsychosoc. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.3748\/wjg.v18.i17.2067","article-title":"Efficacy and safety profile of LCR35 complete freeze-dried culture in irritable bowel syndrome: A randomized, double-blind study","volume":"18","author":"Dapoigny","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/jam.13329","article-title":"The effects of administration of the Lactobacillus gasseri strain CP2305 on quality of life, clinical symptoms and changes in gene expression in patients with irritable bowel syndrome","volume":"122","author":"Nobutani","year":"2017","journal-title":"J. Appl. Microbiol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1177\/2050640617736478","article-title":"Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial","volume":"6","author":"Cremon","year":"2018","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.eng.2020.06.026","article-title":"Lactobacillus plantarum CCFM8610 Alleviates Irritable Bowel Syndrome and Prevents Gut Microbiota Dysbiosis: A Randomized, Double-Blind, Placebo-Controlled, Pilot Clinical Trial","volume":"7","author":"Liu","year":"2021","journal-title":"Engineering"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"9494","DOI":"10.1002\/jsfa.13772","article-title":"Effects of Lactocaseibacillus paracasei subsp. paracasei NTU 101 on gut microbiota: A randomized, double-blind, placebo-controlled clinical study","volume":"104","author":"Lin","year":"2024","journal-title":"J. Sci. Food Agric."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"K\u00f6nig, J., Roca Rubio, M.F., Forsg\u00e5rd, R.A., Rode, J., Axelsson, J., Grompone, G., and Brummer, R.J. (2024). The effects of a 6-week intervention with Limosilactobacillus reuteri ATCC PTA 6475 alone and in combination with L. reuteri DSM 17938 on gut barrier function, immune markers, and symptoms in patients with IBS-D-An exploratory RCT. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0312464"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for Scoping Reviews (PRISMAScR): Checklist and Explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Intern. Med."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/3\/1152\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T12:20:38Z","timestamp":1770034838000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/3\/1152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":124,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["jcm15031152"],"URL":"https:\/\/doi.org\/10.3390\/jcm15031152","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]}}}